InvestorsHub Logo
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

Re: None

Tuesday, 06/13/2017 9:01:09 AM

Tuesday, June 13, 2017 9:01:09 AM

Post# of 6033
Curious to know the possible timeline for a PR on this Zika vaccine development


Heat Biologic Announces Florida Department of Health Awards Three-Year Grant to Develop gp96-based Zika Vaccine

7:15 am ET March 16, 2017 (Benzinga) Print
Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX) announced that Natasa Strbo, M.D., D.Sc., Research Assistant Professor of Microbiology and Immunology at the University of Miami Miller School of Medicine, received a three-year $981,901 grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test gp96-based Zika vaccine. This vaccine is being developed under a collaboration between the University of Miami and Heat's wholly-owned subsidiary, Zolovax, Inc., which has licensed the patent.

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News